Business Portfolio Partner

Company Description

Dr. Reddy’s Laboratories Ltd. is a leading multinational pharmaceutical company based across global locations. Each of our 24,000 plus employees comes to work every day for one collective purpose: to accelerate access to affordable and innovative medicines because Good Health Can’t Wait
.

We started in 1984 with a modest investment, 20 employees and a bold vision. Today, we have research and development centres, manufacturing facilities or a commercial presence in 66 countries.

For nearly four decades, we have stood for access, affordability and innovation based on the bedrock of deep science, progressive people practices and robust corporate governance. As the pharmaceutical industry evolves and undergoes disruption, we see an opportunity – to strengthen our core further (the next steps) and to build the future (the new bets).

‘The Next and the New’ is how we aim to continue to be the partner of choice – purpose-driven, future-ready and sustainable. Our aim is to reach over 1.5 Bn+ patients across the world by 2030 by growing our core businesses and building for the future with sustainability at the core of our purpose and strategy. Sustainability for us means operating in a manner that respects people, planet and purpose – helping us conserve precious resources, serve our patients, create value for stakeholders, give back to society, fulfil our potential and maintain our integrity and transparency.

Dr Reddy’s maintains a work environment, free from discrimination and is an equal opportunity employer. We are committed to employ & nurture all qualified diverse workforce without regard to race, colour religion, nationality, sex, age, disability status, genetics, sexual orientation, gender expression, citizenship or any other characteristic or classification protected by applicable law(s) of the country we operate in. We treasure every talent, and recognize merit and diversity in our organization.

We are looking for an individual in the portfolio analytics role to access epidemiological databases, build early-stage models for drug potential, evaluate COGs (Cost of Goods), and make recommendations on development thresholds. The role includes building visualization tools for senior leader interaction, utilizing quantitative skills for simulations and discounted cash-flow models on advanced programs, and contributing to the evaluation of quantitative models for in-licensing opportunities.

• You will be responsible for owning the models for a set of assets and strategic actions such as in/out licensing. This includes individual molecule long-term forecasting and potential assessment. Your role involves understanding reference drug markets, epidemiology, disease areas, treatment algorithms, IP (Intellectual Property) landscape, pricing trends, competition, and various market factors.
• You will analyze in/out licensing opportunities, biosimilar penetration, market shares, and compute cash flow potential based on constraints, timelines, and new developments. Building financial models, conducting market intelligence, and assessing return potential, costs, and scenarios for in/out licensing are integral aspects of your responsibilities.
• You will be responsible for the development and deployment of the Portfolio Analytics process. This includes analyzing the profitability index and assisting in developing quant/NPV (Net Present Value) based assessments of future value and priorities while assigning financial risks. Additionally, you will access various healthcare and financial databases to gain insights and data needed in the process.
• You will be responsible for portfolio prioritization, supporting the head of Portfolio Management & Strategy, and the Strategy & Product Steering Committee in prioritizing molecules for early development. This includes establishing processes for monitoring and updating decisions based on significant changes in program valuation. Additionally, you will provide data-based contributions to recommendations and framing of portfolio choices, along with offering domain/functional input into strategic portfolio…